K000399 is an FDA 510(k) clearance for the STC PCP INTERCEPT MICRO-PLATE EIA, MODEL 11541. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by OraSure Technologies, Inc. (Bethlehem, US). The FDA issued a Cleared decision on May 15, 2000 after a review of 98 days - within the typical 510(k) review window.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.
View all OraSure Technologies, Inc. devices